Unknown

Dataset Information

0

CD81 costimulation skews CAR transduction toward naive T cells.


ABSTRACT: Adoptive cellular therapy using chimeric antigen receptors (CARs) has revolutionized our treatment of relapsed B cell malignancies and is currently being integrated into standard therapy. The impact of selecting specific T cell subsets for CAR transduction remains under investigation. Previous studies demonstrated that effector T cells derived from naive, rather than central memory T cells mediate more potent antitumor effects. Here, we investigate a method to skew CAR transduction toward naive T cells without physical cell sorting. Viral-mediated CAR transduction requires ex vivo T cell activation, traditionally achieved using antibody-mediated strategies. CD81 is a T cell costimulatory molecule that when combined with CD3 and CD28 enhances naive T cell activation. We interrogate the effect of CD81 costimulation on resultant CAR transduction. We identify that upon CD81-mediated activation, naive T cells lose their identifying surface phenotype and switch to a memory phenotype. By prelabeling naive T cells and tracking them through T cell activation and CAR transduction, we document that CD81 costimulation enhanced naive T cell activation and resultantly generated a CAR T cell product enriched with naive-derived CAR T cells.

SUBMITTER: Schultz LM 

PROVIDER: S-EPMC8812682 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

CD81 costimulation skews CAR transduction toward naive T cells.

Schultz Liora M LM   Czerwinski Debra K DK   Levy Ronald R   Levy Shoshana S  

Proceedings of the National Academy of Sciences of the United States of America 20220201 5


Adoptive cellular therapy using chimeric antigen receptors (CARs) has revolutionized our treatment of relapsed B cell malignancies and is currently being integrated into standard therapy. The impact of selecting specific T cell subsets for CAR transduction remains under investigation. Previous studies demonstrated that effector T cells derived from naive, rather than central memory T cells mediate more potent antitumor effects. Here, we investigate a method to skew CAR transduction toward naive  ...[more]

Similar Datasets

| S-EPMC3277132 | biostudies-literature
| S-EPMC11874623 | biostudies-literature
| S-EPMC5003056 | biostudies-literature
| S-EPMC4555176 | biostudies-literature
| S-EPMC7518635 | biostudies-literature
| S-EPMC8929019 | biostudies-literature
| S-EPMC8274446 | biostudies-literature
| S-EPMC5821198 | biostudies-literature
| S-EPMC5963729 | biostudies-literature
| S-EPMC3767795 | biostudies-literature